• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Alliance for Hope International

(0)Login
Login

Escape

Social iconSocial iconSocial icon

    • About Us
      • Our Team
      • Our Board
      • HOPE Rising Award
      • Lifetime Achievement Award
      • Join Our Mailing List
      • Annual Reports
      • Conference Hope Survey Reports
    • Our History
    • Training
      • Conferences and Events
      • HOPE Hub
      • Privacy Policy
      • Online Resource Library
    • Programs
    • News and Media
    • Shop Now
    • Donate
      • Check us out on Guidestar
      • Supporters
      • Conference Supporters
    • Contact Us

    • Blog
    • News & Media
    • HOPE Hub
    • CFJCN
    • SHOP Now
    • Donate
    • AFHI

    FDA approves Army-developed battlefield TBI blood test

    February 1, 2021

    Story by Todd South

    The Army recently gained approval for a rapid blood test for traumatic brain injury that can be used on the battlefield.

    For at least the past decade researchers have been seeking a way to quickly detect and diagnose TBI, according to an Army statement.

    “A rapid test for TBI is a critical addition to our downrange capability to care for the brain health of our most important weapon system, the warfighter, and help maintain a high state of readiness across the Force,” said Army Brig. Gen. Michael J. Talley, commanding general for the U.S. Army Medical Research and Development Command and Fort Detrick, Maryland.

    The U.S. Food and Drug Administration cleared the test for use last week, according to the statement.

    From 2000 to 2019, more than 400,000 troops sustained a TBI from combat injuries, training accidents and sporting events, according to the statement.

    The test, known as the Abbott i-STAT Alinity TBI plasma assay, identifies two brain-specific protein markers that appear following a TBI incident

    That gives medics, nurses and doctors clear evidence of the condition rather than relying on subjective descriptions. It also reduces the need for head scans.

    “A blood-based biomarker laboratory assay (blood test) for TBI will greatly enhance the ability of DoD medical personnel to objectively assess service members who have suffered a suspected TBI,” said Dr. Krista Caudle, product manager for USAMMDA’s Warfighter Brain Health Project Management Office.

    By avoiding the need for unnecessary evacuations to conduct head scans, the blood test is likely to impact the efficiency of TBI management, Caudle said.

    “Over the years, the program progressed through basic science studies at Walter Reed Army Institute of Research and USAMRDC’s Combat Casualty Care Research Program, then into product development and clinical trials in USAMMDA, and ultimately U.S. FDA clearance,” said Caudle.

    To view the original post, click here.

    Primary Sidebar

    Top Articles

    • Strangulation in sex can increase risk of stroke and brain injuries, distressing study finds
    • read more »
    • Strangled Victims Need Imaging
    • read more »
    • What Parents Need to Know About the Choking Game
    • read more »
    • Choking someone is often prelude to future homicide
    • read more »
    • Strangulation and Domestic Violence Murders
    • read more »

    Join Us Now & stay informed

    • This field is for validation purposes and should be left unchanged.

    our programs

    Nfjca Logo 2018 1
    Trainingiinstitute
    Cha Logo V12.28.18 2
    Justice
    Voices

    Logo Footer 501 W. Broadway, Ste A #625, San Diego, CA 92101 (888) 511-3522 | 1110 Hemphill St. Fort Worth, TX 76104
    © 2022 Alliance for HOPE International. All Rights Reserved. Design by TinyFrog Technologies.

    Login

    Lost Your Password?
    Register
    Don't have an account? Register one!
    Register an Account

    Registration confirmation will be emailed to you.